Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model (Q45858925)

17 December 2017

title

Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model (English)

1 reference

17 December 2017

author name string

Takashi Miyake

1

1 reference

17 December 2017

Motokuni Aoki

2

1 reference

17 December 2017

Suguru Shiraya

3

1 reference

17 December 2017

Kazuo Tanemoto

4

1 reference

17 December 2017

Toshio Ogihara

5

1 reference

17 December 2017

Yasufumi Kaneda

6

1 reference

17 December 2017

Ryuichi Morishita

7

1 reference

17 December 2017

publication date

8 June 2006

1 reference

17 December 2017

Journal of Molecular and Cellular Cardiology

published in

1 reference

17 December 2017

volume

41

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

431-440

1 reference

17 December 2017

Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Early Effects of Arterial Hemodynamic Conditions on Human Saphenous Veins Perfused Ex Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Pathophysiology of vein graft failure: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Endothelium-dependent responses in long-term human coronary artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.006

10.1016/J.YJMCC.2006.04.006

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

16762361

1 reference

17 December 2017